Clincosm LogoSign in Get a demo

Neuroblastoma

Showing 1 - 25 of 343
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Neuroblastoma Trial in Esplugues De Llobregat (Immersive virtual reality imaging, Gold standard imaging)

Recruiting
  • Neuroblastoma
  • Immersive virtual reality imaging
  • Gold standard imaging
  • Esplugues De Llobregat, Barcelona, Spain
    Hospital Sant Joan de Déu
Mar 22, 2023

Solid Tumor, Haematological Malignancy, Malignant Tumor Trial in United Kingdom (Alectinib)

Recruiting
  • Solid Tumor
  • +10 more
  • Belfast, United Kingdom
  • +25 more
Mar 14, 2023

Neuroblastoma Trial (horse therapy)

Not yet recruiting
  • Neuroblastoma
  • horse therapy
  • (no location specified)
Feb 22, 2023

Neuroblastoma, Solid Tumor Trial (APG-115, APG-2575)

Not yet recruiting
  • Neuroblastoma
  • Solid Tumor
  • (no location specified)
Jan 18, 2023

Synovial Sarcoma, Malignant Peripheral Nerve Sheath Tumor (MPNST), Neuroblastoma Trial in United States (Afamitresgene

Not yet recruiting
  • Synovial Sarcoma
  • +3 more
  • Afamitresgene autoleucel
  • Palo Alto, California
  • +3 more
Dec 6, 2022

Pediatric Cancer, Hodgkin Disease, CD30-Positive DLBCL Trial in Milwaukee (anti-CD30 Bispecific Antibody-armed

Not yet recruiting
  • Pediatric Cancer
  • +11 more
  • anti-CD30 Bispecific Antibody-armed anti-CD3-Activated Autologous T-cells (CD30 biAb-AATC)
  • Milwaukee, Wisconsin
    Children's Wisconsin
Sep 14, 2022

Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Neuroblastoma Trial in Worldwide (Idasanutlin, Venetoclax,

Recruiting
  • Acute Myeloid Leukemia (AML)
  • +3 more
  • Phoenix, Arizona
  • +18 more
Aug 24, 2022

Ewing Sarcoma, Solid Tumors, Rhabdoid Tumor Trial in Worldwide (Palbociclib, Temozolomide, Irinotecan)

Recruiting
  • Ewing Sarcoma
  • +6 more
  • Birmingham, Alabama
  • +83 more
Aug 19, 2022

Endocrine Neoplasms

Recruiting
  • Endocrine Tumors
  • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Aug 18, 2022

    Neuroblastoma Trial in Worldwide (LY3295668 Erbumine, Topotecan, Cyclophosphamide)

    Active, not recruiting
    • Neuroblastoma
    • LY3295668 Erbumine
    • +2 more
    • San Francisco, California
    • +21 more
    Aug 17, 2022

    Ganglioneuroblastoma, Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma Trial in Worldwide (Carboplatin,

    Recruiting
    • Ganglioneuroblastoma
    • +3 more
    • Birmingham, Alabama
    • +219 more
    Aug 17, 2022

    Ganglioneuroblastoma, Nodular, Neuroblastoma Trial in Worldwide (Dinutuximab, Irinotecan, Isotretinoin)

    Active, not recruiting
    • Ganglioneuroblastoma, Nodular
    • Neuroblastoma
    • Dinutuximab
    • +4 more
    • Mesa, Arizona
    • +77 more
    Aug 17, 2022

    Ganglioneuroblastoma, Neuroblastoma Trial in Canada, Puerto Rico, United States (procedure, drug, biological, radiation)

    Recruiting
    • Ganglioneuroblastoma
    • Neuroblastoma
    • Autologous Hematopoietic Stem Cell Transplantation
    • +18 more
    • Birmingham, Alabama
    • +158 more
    Aug 17, 2022

    International PPB/DICER1 Registry

    Recruiting
    • Pleuropulmonary Blastoma
    • +14 more
      • Minneapolis, Minnesota
        Children's Minnesota
      Aug 16, 2022

      Neuroblastoma, Pediatric Cancer Trial in New York (Cyclophosphamide, Topotecan, Vincristine)

      Recruiting
      • Neuroblastoma
      • Pediatric Cancer
      • New York, New York
        Memorial Sloan Kettering Cancer Center
      Aug 11, 2022

      Neuroblastoma Trial in Houston (GINAKIT Cells, Cyclophosphamide, Fludarabine)

      Recruiting
      • Neuroblastoma
      • GINAKIT Cells
      • +2 more
      • Houston, Texas
        Texas Children's Hospital
      Aug 5, 2022

      Ependymoma, Ewing Sarcoma, High-grade Glioma Trial in Worldwide (Nivolumab, NKTR-214)

      Completed
      • Ependymoma
      • +9 more
      • Nivolumab
      • NKTR-214
      • Little Rock, Arkansas
      • +17 more
      Jul 29, 2022

      Neuroblastoma Trial in United States (18F-MFBG)

      Recruiting
      • Neuroblastoma
      • Los Angeles, California
      • +6 more
      Jul 19, 2022

      Neuroblastoma Trial in New York (Hu3F8, GM-CSF, Isotretinoin)

      Active, not recruiting
      • Neuroblastoma
      • Hu3F8
      • +2 more
      • New York, New York
        Memorial Sloan Kettering Cancer Center
      Jul 1, 2022

      Pediatric Solid Tumor, Osteosarcoma, Rhabdomyosarcoma Trial in Memphis (Fludarabine, Cyclophosphamide, MESNA)

      Recruiting
      • Pediatric Solid Tumor
      • +15 more
      • Memphis, Tennessee
        St. Jude Children's Research Hospital
      Jun 30, 2022

      Neuroblastoma Trial in Guangzhou (Anti Thymocyte Globulin, Fludarabine, Cyclophosphamide injection)

      Not yet recruiting
      • Neuroblastoma
      • Anti Thymocyte Globulin
      • +10 more
      • Guangzhou, Guangdong, China
        Sun Yat-sen Memorial Hospital, Sun Yat-sen University
      Jun 29, 2022

      Neuroblastoma Trial (Topotecan, Temozolomide, Ribociclib)

      Not yet recruiting
      • Neuroblastoma
      • (no location specified)
      Jun 17, 2022

      Neuroblastoma Trial in New York (dietary supplement, drug, biological)

      Recruiting
      • Neuroblastoma
      • β-glucan
      • +2 more
      • New York, New York
        Memorial Sloan Kettering Cancer Center
      Jun 16, 2022

      Neuroblastoma Trial in Los Angeles (Dinutuximab with Chemotherapy)

      Not yet recruiting
      • Neuroblastoma
      • Dinutuximab with Chemotherapy
      • Los Angeles, California
        Childrens Hospital Los Angeles
      Jun 13, 2022

      Neuroblastoma, Refractory Neuroblastoma, Relapsed Neuroblastoma Trial in Atlanta (Ex Vivo Expanded Allogeneic ?d T Cells in

      Not yet recruiting
      • Neuroblastoma
      • +2 more
      • Ex Vivo Expanded Allogeneic γδ T Cells in Combination with Dinutuximab, Temozolomide, Irinotecan and Zoledronate
      • Atlanta, Georgia
        Children's Healthcare of Atlanta
      May 31, 2022